FITC-RR-Au-ZnO-RGD were -2.23 ± 0.15 and -5.34 ± 0.31 mV, respectively. On comparison of these values, 3-aminopropionic acid conjugation significant changed the zeta-potential of Au-ZnO NPs, but RGD peptide and FITC-RR conjugation caused the most pronounced difference. These observations strongly suggested successful surface conjugation of RGD and FITC-RR peptides to the NPs. To further confirm this aspect, Au-ZnO NPs were mixed with the RGD and FITC-RR peptides first and thoroughly washed, which had a zeta potential value of 16.2 ± 3.5 mV, significantly different from that of FITC-RR-Au-ZnO-RGD (-5.34 ± 0.31 mV).
Characterization of ROS Formation in Vitro.
The catalytic abilities of ZnO or FITC-RR-AuZnO-RGD were evaluated in vitro according to a previously reported method 4 with some modifications.
TEMPO-BDP 5 synthesized by our group was used as the fluorescent probe for determination of ROS.
The NPs (50 μg/mL) were initially incubation in the xanthine/xanthine oxidase (X/XO) superoxide generating system (containing 21 mM EDTA, 7 mM xanthine, 3 milliunits/mL xanthine oxidase) at 37°C for 20 min with vortexing. Then the mixture was centrifuged at 11000g for 5 min, and a clear supernatant solution was discarded. The precipitated NPs were incubated with 80 μL of a solution of Enzymatic Activity of FITC-RR-Au-ZnO-RGD for Cathepsin B. 50 µg of FITC-RR-Au-ZnO-RGD NPs were incubated with 2 μg recombinant cathepsin B in 1.0 mL of assay buffer 6 (88 mM KH 2 PO 4 , 12 mM Na 2 HPO 4 , 1.33 mM EDTA-Na 2 , 2.7 mM L-cysteine, pH 6.0) for 2 h at 37 °C.
Cathepsin B inhibitor Z-Phe-Phe-FMK (50 μM) was added in the control reaction. Then the detection sensitivity was studied by co-incubating FITC-RR-Au-ZnO-RGD (50 µg/mL) with 0.1, 0.5, 1, 2 and 4 μg of Cathepsin B for 1 h at 37 °C. The fluorescence spectra of the enzymatic reaction solutions heat-inactivated fetal bovine serum (FBS), 100 U/mL penicillin and 100 μg/mL streptomycin (Invitrogen, Carlsbad, CA).
Internalization of FITC-RR-Au-ZnO-RGD. HepG2 and HL7702 cells were seeded at a density of 5×10 6 cells/well in a 6 well-plate. After 24 h, the cells were incubated with FITC-RR-Au-ZnO-RGD (50 µg/mL) for 0.5 h and then washed three times to remove unbound NPs. To measure gold content inside lysosome, we used a kit from Sigma-Aldrich for lysosome isolation. Cell fractionation and lysosome isolation were performed according to the manufacturer's instructions. The resulting lysosomal fractions were treated with 0.2 mL of aqua regia (3:1 hydrochloric acid/nitric acid).
Following the incubation overnight, the sample was diluted to 5 mL using ultrapure water and then analyzed for total gold content by ICP-AES (Thermo, IRIS Advantage, 242.795 nm). Based on the previous protocol, 7 the number of Au a cell can uptake was calculated.
Cytotoxicity Assays. Cytotoxicity was measured by using the MTT assay in the logarithmic phase of cell growth. HepG2 and HL7702 cells were seeded at a density of 5×10 4 cells/well in a 96 well-plate and incubated for 24 h before adding the test substance. Then fresh medium containing increasing concentrations of FITC-RR-Au-ZnO-RGD was added to each well. After 24 h incubation, medium was removed and replaced with medium containing MTT (0.5 mg/mL). Cells were incubated at 37 °C for another 4 h after which medium was removed. DMSO (100μL) was added to lyse the cells and dissolve the formazan produced. The absorbance at 570 nm of each well was monitored using a microplate reader. Viability was calculated based on the recorded data.
Characterization of ROS Formation in Cells.
HepG2 and HL7702 cells were seeded at a density of 5×10 4 cells/well in a 96 well-plates and incubated for 24 h. Cells were loaded with TEMPO-BDP (2 μM in 10 mM HEPES, 0.10M DMSO) and were incubated at 37 °C for 30 min. The probe was removed, and the cells were washed twice with PBS. Then fresh medium containing FITC-RR-Au-ZnO-RGD (50 µg/mL) were added to each well. The fluorescence spectrum was recorded every 30 min for a period of 6 h at 37 °C via excitation at 560 nm and emission at 601 nm on a fluorescence plate reader (FLUOstar Optima, BMG Labtech, Germany). Analysis of Cathepsin B Activity. To measure cathepsin activity in the cytosol, cytosolic fractions were prepared as described by Nakayama 8 with minor modifications. Briefly, HepG2 cells in the logarithmic growth phase were plated in 6-well cell culture plates at initial densities of 5×10 6 /well and incubated for 24 h. Fresh medium containing FITC-RR-Au-ZnO-RGD (50 µg/mL) was added to the cells and incubated for 0.5, 1, 3, or 6 h. After incubation, cells were washed with PBS, centrifuged at 600g for 5 min and resuspended in an appropriate extraction buffer (200 mM mannitol, 68 mM sucrose, 50 mM PIPES-KOH (pH 7.4), 50 mM KCl, 2 mM MgCl 2 , 1 mM EDTA, 1 mM dithiothreitol (DTT), 1 mM pefablock, 10 μg/mL leupeptin). After 30 minutes on ice, cells were lysed with a glass dounce homogenizer with 100 strokes of the B pestle, followed by centrifugation at 750g for 10 minutes at 4°C to remove the nuclei and unbroken cells. Supernatants (enucleated whole-cell lysates) were then centrifuged at 15 000g for 30 minutes at 4°C to remove lysosomes and mitochondria. The resultant supernatants were further centrifuged at 100 000g for 1 hour at 4°C, and the final supernatants (cytosolic fractions) were collected. Cathepsin B activity was detected using a cathepsin B activity 6 fluorometric assay kit. For each well in a 96 well microplate, cytosolic fractions (50 μL), reaction buffer (50 μL), and cathepsin B substrate (Ac-RR-AFC, 2 μL) were combined. The samples were then incubated at 37°C for 2 h and then characterized with a microplate reader operating at a wavelength of 405 nm.
Imaging of LMP-Dependent
Western Blotting. HepG2 cells in the logarithmic growth phase were plated in 6-well cell culture plates at initial densities of 5×10 6 /well and incubated for 24 h. Fresh medium containing FITC-RR-AuZnO-RGD (50 µg/mL) was added to the cells and incubated for 0.5, 1, 3 or 6 h. After incubation, cells were collected, washed with cold PBS twice and centrifuged at 1200g for 5 min. The cell pellets were permeabilized with 100 μg/mL digitonin at 4 °C for 10 min. The supernatant representing the cytosol and the mitochondria-containing pellet fraction were separated by centrifugation and denatured based on the previous protocol. 9 The amount of protein was measured using a protein assay kit (DC protein assay reagent, Bio-Rad, Hercules, CA, USA). Equal amounts of protein (50 μg) were resolved on 12.5% SDS-PAGE gels and electro-blotted onto a nitrocellulose membrane (BioRad) in 20% methanol, 25 mM Tris and 192 mM glycine. Membranes were then blocked with 5% non-fat dry milk in TTBS (25 mM TrisHCl, 150 mM NaCl, and 0.2% Tween-20) overnight at 4 °C. Next, membranes were incubated for 1 h with different primary antibodies against tBid, cytochrome c and activated caspase-3, respectively, followed by HRP-conjugated secondary antibody (1:1000) for 1 h. Detection was carried out by incubating membranes for 5 min with the enhanced chemiluminescence reagent, followed by exposure to ECL X-ray film (Amersham Biosciences, Piscataway, NJ).
Supplementary Figures
Scheme S1. Schematic illustration of the synthesis of FITC-RR-Au-ZnO-RGD. The spectra were acquired in 10 mM HEPES buffer (pH 7.4). Mitochondrial and cytosolic fractions were prepared and subjected to western blot analysis for tBid, cytochrome c and caspase 3. β-actin was used as the loading control.
